VANCOUVER, BC , March 31, 2026 /CNW/ - BTQ Technologies Corp. ("BTQ" or the "Company") (Nasdaq: BTQ) (CBOE CA: BTQ), a global quantum technology company focused on securing mission-critical networks, is pleased to announce that Dr. Ro Cammarota is joining the Company's U.S. team to support the development, commercialization, and strategic partnership efforts for BTQ's post-quantum semiconductor product, QCIM.
Read more at newswire.ca
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
BTQ Technologies Appoints Dr. Ro Cammarota to Accelerate QCIM Product Development, Commercialization, and Global Partnerships
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
